Skip to content
Clinical Trials – home
Aalborg University Hospital
Sponsor

Aalborg University Hospital

Denmark Hobrovej 18-22, 9000 Aalborg, Denmark

About the sponsor

The institution demonstrates significant involvement in advanced cardiovascular imaging techniques, with particular emphasis on cardiac computed tomography and coronary artery assessment. Research activities focus on evaluating coronary stenosis and developing improved diagnostic protocols for patients with suspected or confirmed coronary artery disease. Studies examine the clinical utility of CT coronary angiography in various patient populations, including those presenting with acute chest pain and individuals requiring comprehensive cardiac evaluation.

  • Coronary CT Angiography Optimization
  • Cardiac Imaging Protocol Development
  • Non-invasive Coronary Assessment
  • Chest Pain Diagnostic Pathways

The research portfolio includes investigations into myocardial perfusion imaging and the integration of multiple imaging modalities to enhance diagnostic accuracy in cardiovascular conditions. Special attention is given to refining imaging techniques that can guide clinical decision-making in ischemic heart disease.

About Specializations

Aalborg University Hospital runs clinical trials in conditions such as Follicular lymphoma, Drug use disorder, Primary mediastinal large B-cell lymphoma, Anaplastic large cell lymphoma T- and null-cell types, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

17 clinical trials

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Aalborg University Hospital
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:NALDEMEDINE
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amiodarone Hydrochloride
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Cariprazine
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Zoledronic Acid
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Abatacept
  • Sponsor:Aalborg University Hospital

Herpes simplex meningitis

Not yet recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Aciclovir
  • Sponsor:Aalborg University Hospital

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.